OpenAI for Science is an initiative through which the company addresses scientists – and certainly wants to retain them. Now OpenAI is launching Prism, an AI-based workspace for scientific writing.

A recent review of over 312 studies has identified dozens of unique uses of roadkill in scientific research. The review, published in Biology Letters, discusses the advantages of using roadkill ...

OpenAI is releasing a new app called Prism today, and it hopes it does for science what coding agents like Claude Code and its own Codex platform have done for programming. Prism builds on Crixet, a ...

Investing in mutual funds can sometimes feel challenging particularly when one is unsure how money might grow over time. A Systematic Investment Plan (SIP) Calculator makes this process simpler. This ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Boston Scientific’s planned $14.5 billion acquisition of ...

Strive (NASDAQ: ASST) completed its acquisition of Semler Scientific on Friday, consolidating bitcoin holdings to become the 11th largest public corporate holder of the cryptocurrency globally. The ...

The companies will work together to help pharmaceutical organizations improve efficiency and deliver better outcomes for patients. BOSTON, Jan. 13, 2026 /PRNewswire/ -- TetraScience, the Scientific ...

A new paper published in The Gerontologist provides the most comprehensive scientific response to date addressing recent critiques of the so-called "Blue Zones," regions of the world known for ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Boston Scientific has been ...

For me, buying a publicly traded stock is no different than buying an interest in a private business. In either case, I would only invest in a company that’s well-managed, with a valuable product line ...

Roth Capital Partners believes Core Scientific looks more valuable as a potential deal with CoreWeave is in danger of falling apart. The investment firm upgraded shares to buy from neutral. Analyst ...

CoreWeave CEO Michael Intrator said the company would not raise its acquisition price for Bitcoin miner Core Scientific. Intrator told CNBC that Core Scientific is a "nice to have, not a need to have.